• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » The MoCA: A Better MMSE?

The MoCA: A Better MMSE?

May 1, 2008
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD
Most psychiatrists rely on the Folstein Mini Mental State Exam for a rapid, office-based neuropsychological assessment. It is what we were trained on, and we have given it to so many patients that we can pretty much reel off the items from memory.

But the MMSE has some serious limitations. While it is quite sensitive at picking up moderate to severe dementia, it is very poor at screening for patients with mild cognitive impairment (MCI), which is diagnosed in patients who have abnormally poor memory for their age but who do not show significant functional impairment (see TCPR May 2007). Patients with MCI progress to dementia at a rate of 10-15% per year, far higher than the baseline rate of 1-2% per year in normal elderly. In the typical scenario, an elderly patient will come in complaining of memory lapses, and will want to know if they have “normal” age related memory loss or something more serious.

The MMSE is generally unhelpful in such cases, because it’s a little too easy: both normal and MCI patients will typically score 26 or above, the usual cut-off point for cognitive impairment.

But a hot new test, called the Montreal Cognitive Assessment (MoCA) appears to work much better. The test, developed in Quebec with some help from UCLA’s Jeffrey Cummings, was developed specifically to better diagnose MCI. Think of the MoCA as a more challenging version of the MMSE; because it is more challenging, it will pick up a higher proportion
of patients with more subtle amounts of cognitive impairment. Like the MMSE, it is quick to administer (about 10 minutes) and has a maximum of 30 points. In a study comparing the MMSE with the MoCA, the MMSE had a sensitivity of only 18% to detect MCI (meaning it missed 82% of the people with MCI), while the MoCA detected 90% of MCI subjects (Nasreddine ZS et al., J Am Geriatr Soc 2005;53:695-699).

As always, though, high sensitivity comes at the price of somewhat lower specificity (false positives). In the study cited above, for example, the specificity for MCI was 87%, meaning that 13% of actually normal people will be falsely labeled as impaired -- still quite accurate. The really nice thing about the MoCA is that the test and detailed instructions are available (in
several languages) for free at www.mocatest.org. We think the MoCA should become the test of choice for fairly high functioning patients who come in worried about memory loss.

TCPR Verdict:

MoCA: Better than MMSE for mild cognitive impairment.

 
General Psychiatry
KEYWORDS dementia diagnostic_testing
www.thecarlatreport.com
Issue Date: May 1, 2008
SUBSCRIBE NOW
Table Of Contents
The MoCA: A Better MMSE?
Tests to Detect Malingering
Tamoxifen appears effective for mania
Orally disintegrating Zyprexa appears to cause less weight gain
A new study is consistent with FDA’s black box requirements for antidepressants.
The Utility of Neuropsychological Testing
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.